Category: Business of health

4 3/16/2016

Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing

1 3/10/2016

Xarelto controversy highlights need for more transparency at NEJM

10 3/8/2016

Investigation of Alzheimer’s Association in-fighting didn’t address the role of corporate sponsorships

3 3/1/2016

“Low T” tease: rosy anecdotes and the reality of testosterone treatment effects

7 2/10/2016

Groups push pharma agenda under the guise of patient advocacy

1/15/2016

Faulty medical devices stay on the market even after manufacturers know there are problems

2 1/13/2016

University of Maryland launches institutional review of chocolate milk study first flagged by HealthNewsReview.org

1/13/2016

Grail’s search for a universal cancer screen: noble quest or fool’s errand?

1 1/12/2016

Hypewatch: Journalists need to pour some cold water into that “Grail”

1 1/8/2016

Is more testing really the way to save American healthcare?